Showing 1 - 3 of 3
Background: Research sponsored by the pharmaceutical industry is often assumed to be more likely to report favourable cost-effectiveness results. Objective: To determine whether there was a relationship between the source of funding and the reporting of positive results. Methods: We conducted a...
Persistent link: https://www.econbiz.de/10008602826
Osteoporotic fragility fractures constitute a significant public health concern. The lifetime risk of any osteoporotic fracture is very high (40–50% in women and 13–22% in men). Fractures are associated with significant mortality and morbidity and represent a substantial economic burden to...
Persistent link: https://www.econbiz.de/10011001629
Multiple sclerosis (MS) is a disease of the CNS, typically striking adults during the primary productive time of their life. The symptoms of MS can restrict the individual's physical activity and income-earning ability, resulting in a major financial burden on the patient, family, health system...
Persistent link: https://www.econbiz.de/10008620568